MetaPepticon: automated prediction of anticancer peptides from microbial genomes and metagenomes
PeerJ · 27.03.2026 · 14 · e20990
DOI: 10.7717/peerj.20990 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, online erschienen am 27.03.2026. Verfasst von Ahmet Arıhan Erözden und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Division, Department of Biology, Faculty of Science, Istanbul University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Antineoplastic Agents, Peptides, Metagenome, Genome, Microbial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Projects Coordination Unit of Istanbul University.
Abstract (Originalsprache)
Background
Anticancer peptides (ACPs) are increasingly recognized as promising therapeutic candidates due to their ability to selectively target cancer cells. However, the systematic discovery of novel ACPs, particularly from high-throughput sequencing datasets, remains hindered by technical and methodological limitations. Current prediction frameworks require pre-extracted peptide sequences, involve manual preprocessing, and yield variable results, which restricts their applicability for large-scale, data-driven discovery.
Methods
To address these limitations, we developed MetaPepticon, a modular, end-to-end pipeline for the discovery of ACP candidates from diverse sequencing inputs, including raw genomic, metagenomic, transcriptomic, and metatranscriptomic reads, as well as assembled contigs and peptide sequences. MetaPepticon automates quality control, filtering, assembly, small open reading frame prediction, ACP classification using multiple predictive algorithms, and in silico toxicity filtering.
Results
MetaPepticon enables scalable and reproducible ACP prediction from raw sequences through integration of multiple predictors within a configurable agreement framework. Applied to 41,171 microbial genomes and 4,072,884 peptides, MetaPepticon identified 10,725 moderate-agreement ACP candidates, including 4,590 novel, non-toxic peptides. MetaPepticon expands the practical applicability of existing ACP prediction methods to high-throughput sequencing data and is freely available at: https://github.com/arikanlab/MetaPepticon .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology Division, Department of Biology, Faculty of Science, Istanbul University, Istanbul, Turkey.
- Institute of Graduate Studies in Science, Istanbul University, Istanbul, Turkey.
- Department of Medical Biology and Genetics, Faculty of Medicine, Maltepe University, Istanbul, Turkey.
Förderung
- Scientific Research Projects Coordination Unit of Istanbul University
Zitieren
APA
Erözden, A. A., Tavşanlı, N., Demirel, G., Sanli, N. O., Çalışkan, M., & Arıkan, M. (2026). MetaPepticon: automated prediction of anticancer peptides from microbial genomes and metagenomes. PeerJ, 14, e20990. https://doi.org/10.7717/peerj.20990
Vancouver
Erözden AA, Tavşanlı N, Demirel G, Sanli NO, Çalışkan M, Arıkan M. MetaPepticon: automated prediction of anticancer peptides from microbial genomes and metagenomes. PeerJ. 2026;14:e20990. doi:10.7717/peerj.20990
BibTeX
@article{Erzden2026,
author = {Erözden, Ahmet Arıhan and Tavşanlı, Nalan and Demirel, Gamze and Sanli, Nazmiye Ozlem and Çalışkan, Mahmut and Arıkan, Muzaffer},
title = {MetaPepticon: automated prediction of anticancer peptides from microbial genomes and metagenomes},
journal = {PeerJ},
year = {2026},
volume = {14},
pages = {e20990},
doi = {10.7717/peerj.20990}
}
EUVIMED